Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study

Arrigo F G Cicero, Giuseppe Derosa, Livia Pisciotta, Carlo Barbagallo

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The main guidelines for cardiovascular disease prevention suggest that nutraceuticals could be an efficacious tool to improve lipid pattern. Our aim was to carry out a clinical trial comparing the metabolic effects of a combined nutraceutical containing both red yeast rice and polyunsaturated fatty acids (PUFAs) and a phytosterol-based approach in a setting of clinical practice. This was a multicenter open study with parallel control. We consecutively enrolled 107 pharmacologically untreated subjects affected by primary polygenic hypercholesterolemia and metabolic syndrome, assigned to 8-week treatment with a combined treatment with red yeast rice (Dif1Stat®, including 5mg monacolin K) and 610mg PUFAs. A parallel group of 30 subjects with similar characteristics was treated with phytosterols 1600mg/die. In the combined nutraceutical group, compared with the baseline level, we observed a significant decrease in total cholesterol (TC; -42.50±18.1mg/dL), low-density lipoprotein cholesterol (LDL-C; -37.6±13.6mg/dL), triglycerides (TG; -19.8±25.1mg/dL), and non-HDL-C (-43.1±17.7mg/dL) (all P

Original languageEnglish
Pages (from-to)1270-1273
Number of pages4
JournalJournal of Medicinal Food
Volume18
Issue number11
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Dietary Supplements
Multicenter Studies
Phytosterols
Unsaturated Fatty Acids
Lipids
Lovastatin
Hypercholesterolemia
LDL Cholesterol
Triglycerides
Cardiovascular Diseases
Cholesterol
Clinical Trials
Guidelines
Therapeutics
red yeast rice

Keywords

  • Dietary supplements
  • Hypercholesterolemia
  • Monacolins
  • Nutraceuticals
  • Phytosterols
  • PUFA
  • Red yeast rice

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice : A Multicenter Study. / Cicero, Arrigo F G; Derosa, Giuseppe; Pisciotta, Livia; Barbagallo, Carlo.

In: Journal of Medicinal Food, Vol. 18, No. 11, 01.11.2015, p. 1270-1273.

Research output: Contribution to journalArticle

@article{b6491500126c4dea8d303f1353e109ae,
title = "Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study",
abstract = "The main guidelines for cardiovascular disease prevention suggest that nutraceuticals could be an efficacious tool to improve lipid pattern. Our aim was to carry out a clinical trial comparing the metabolic effects of a combined nutraceutical containing both red yeast rice and polyunsaturated fatty acids (PUFAs) and a phytosterol-based approach in a setting of clinical practice. This was a multicenter open study with parallel control. We consecutively enrolled 107 pharmacologically untreated subjects affected by primary polygenic hypercholesterolemia and metabolic syndrome, assigned to 8-week treatment with a combined treatment with red yeast rice (Dif1Stat{\circledR}, including 5mg monacolin K) and 610mg PUFAs. A parallel group of 30 subjects with similar characteristics was treated with phytosterols 1600mg/die. In the combined nutraceutical group, compared with the baseline level, we observed a significant decrease in total cholesterol (TC; -42.50±18.1mg/dL), low-density lipoprotein cholesterol (LDL-C; -37.6±13.6mg/dL), triglycerides (TG; -19.8±25.1mg/dL), and non-HDL-C (-43.1±17.7mg/dL) (all P",
keywords = "Dietary supplements, Hypercholesterolemia, Monacolins, Nutraceuticals, Phytosterols, PUFA, Red yeast rice",
author = "Cicero, {Arrigo F G} and Giuseppe Derosa and Livia Pisciotta and Carlo Barbagallo",
year = "2015",
month = "11",
day = "1",
doi = "10.1089/jmf.2015.0024",
language = "English",
volume = "18",
pages = "1270--1273",
journal = "Journal of Medicinal Food",
issn = "1096-620X",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice

T2 - A Multicenter Study

AU - Cicero, Arrigo F G

AU - Derosa, Giuseppe

AU - Pisciotta, Livia

AU - Barbagallo, Carlo

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The main guidelines for cardiovascular disease prevention suggest that nutraceuticals could be an efficacious tool to improve lipid pattern. Our aim was to carry out a clinical trial comparing the metabolic effects of a combined nutraceutical containing both red yeast rice and polyunsaturated fatty acids (PUFAs) and a phytosterol-based approach in a setting of clinical practice. This was a multicenter open study with parallel control. We consecutively enrolled 107 pharmacologically untreated subjects affected by primary polygenic hypercholesterolemia and metabolic syndrome, assigned to 8-week treatment with a combined treatment with red yeast rice (Dif1Stat®, including 5mg monacolin K) and 610mg PUFAs. A parallel group of 30 subjects with similar characteristics was treated with phytosterols 1600mg/die. In the combined nutraceutical group, compared with the baseline level, we observed a significant decrease in total cholesterol (TC; -42.50±18.1mg/dL), low-density lipoprotein cholesterol (LDL-C; -37.6±13.6mg/dL), triglycerides (TG; -19.8±25.1mg/dL), and non-HDL-C (-43.1±17.7mg/dL) (all P

AB - The main guidelines for cardiovascular disease prevention suggest that nutraceuticals could be an efficacious tool to improve lipid pattern. Our aim was to carry out a clinical trial comparing the metabolic effects of a combined nutraceutical containing both red yeast rice and polyunsaturated fatty acids (PUFAs) and a phytosterol-based approach in a setting of clinical practice. This was a multicenter open study with parallel control. We consecutively enrolled 107 pharmacologically untreated subjects affected by primary polygenic hypercholesterolemia and metabolic syndrome, assigned to 8-week treatment with a combined treatment with red yeast rice (Dif1Stat®, including 5mg monacolin K) and 610mg PUFAs. A parallel group of 30 subjects with similar characteristics was treated with phytosterols 1600mg/die. In the combined nutraceutical group, compared with the baseline level, we observed a significant decrease in total cholesterol (TC; -42.50±18.1mg/dL), low-density lipoprotein cholesterol (LDL-C; -37.6±13.6mg/dL), triglycerides (TG; -19.8±25.1mg/dL), and non-HDL-C (-43.1±17.7mg/dL) (all P

KW - Dietary supplements

KW - Hypercholesterolemia

KW - Monacolins

KW - Nutraceuticals

KW - Phytosterols

KW - PUFA

KW - Red yeast rice

UR - http://www.scopus.com/inward/record.url?scp=84946014500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946014500&partnerID=8YFLogxK

U2 - 10.1089/jmf.2015.0024

DO - 10.1089/jmf.2015.0024

M3 - Article

AN - SCOPUS:84946014500

VL - 18

SP - 1270

EP - 1273

JO - Journal of Medicinal Food

JF - Journal of Medicinal Food

SN - 1096-620X

IS - 11

ER -